In this study, we investigated that a decreased DRAK1 protein stability followed by upregulation of TRAF6 levels, and TRAF6-mediated NF-κB signaling pathway, promotes the malignancy of paclitaxel-resistant cervical cancer cells. The gene discussed is STK17A; the disease is cervical cancer.